Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Orally available pharmaceutical formulation suitable for improved management of movement disorders

Orally available pharmaceutical formulation suitable for improved management of movement disorders

US Patent 10561618 · Granted Feb 18, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tesofensine and beta blocker combination formulations2024
Pulsatile drug delivery system for treating morning akinesia2024
Pulsatile drug delivery system for treating morning akinesia2024
Composition comprising suplatast tosilate2023
Suplatast tosilate for use in the treatment of cough associated with interstitia2023
Suplatast tosilate for use in the treatment of cough associated with interstitia2023
Use of buspirone metabolites2022
Use of buspirone metabolites2022
Tesofensine and beta blocker combination formulations2022
Tesofensine and beta blocker combination formulations2020
Combinations of serotonin receptor agonists for treatment of movement disorders2020
Tesofensine and beta blocker combination formulations2020